AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

6.90USD
26 Nov 2014
Price Change (% chg)

$0.27 (+4.07%)
Prev Close
$6.63
Open
$6.62
Day's High
$6.98
Day's Low
$6.56
Volume
273,007
Avg. Vol
640,304
52-wk High
$13.64
52-wk Low
$5.22

ACRX.O

Chart for ACRX.O

About

AcelRx Pharmaceuticals, Inc. is a United States-based Pharmaceutical Company, which develops and commercializes therapies for the treatment of pain. The Company's products include ARX-01 Sufentanil NanoTab PCA System, to solve the problems associated with post-operative intravenous patient-controlled analgesia (IV PCA); ARX-02... (more)

Overall

Beta: 1.93
Market Cap (Mil.): $301.58
Shares Outstanding (Mil.): 43.71
Dividend: --
Yield (%): --

Financials

  ACRX.O Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -0.04 -- --
ROI: -2.29 -2.35 17.27
ROE: -3.15 -3.55 18.18
Search Stocks

AcelRx stock plunges after FDA rejects pain drug device

- Shares of AcelRx Pharmaceuticals Inc plunged almost 40 percent after the U.S. Food and Drug Administration rejected its pain treatment late on Friday.

28 Jul 2014

UPDATE 1-AcelRx stock plunges after FDA rejects pain drug device

July 28 - Shares of AcelRx Pharmaceuticals Inc plunged almost 40 percent after the U.S. Food and Drug Administration rejected its pain treatment late on Friday.

28 Jul 2014

AcelRx stock plunges after FDA rejects pain drug device

July 28 - Shares of AcelRx Pharmaceuticals Inc plunged nearly 28 percent in premarket trading, after the U.S. Food and Drug Administration rejected its pain drug device, Zalviso, late on Friday.

28 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks